ArticleCancer immunology, immunotherapy : CII2023

Extended duration of treatment using reduced-frequency dosing of anti-PD-1 therapy in patients with advanced melanoma and Merkel cell carcinoma.

Lisa May Ling Tachiki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.